论文信息 - An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways

An Unusual Recurrence of Signet Ring Cell Gastric Adenocarcinoma Treated by Right Hemicolectomy, Pancreaticoduodenectomy, and IVC Resection: Controversies and Dilemmas of Following Standard Treatment Pathways

We present the case of a 67-year-old male patient with a past history of previously resected T3 right adrenocortical carcinoma and T3N1 signet ring cell adenocarcinoma of the stomach who presented with recurrence of gastric cancer in the form of a large solitary mass in the right abdomen. He was treated with ECX (epirubicin, cisplatin and capecitabine) chemotherapy and multivisceral resection. This recurrence pattern is the first such description in the literature, and we discuss the controversies and arguments in favour of offering surgical resection.

D. Cunningham | P. Zentler-Munro | M. Sodergren | S. Mudan | K. Brammer

[1] G. Spolverato,et al. Is Linitis Plastica a Contraindication for Surgical Resection: A Multi-Institution Study of the U.S. Gastric Cancer Collaborative , 2016, Annals of Surgical Oncology.

[2] Anne Berger,et al. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. , 2015, World journal of gastroenterology.

[3] H. Isomoto,et al. Early stage signet ring cell carcinoma of the colon examined by magnifying endoscopy with narrow-band imaging: a case report , 2015, BMC Gastroenterology.

[4] B. Fernandez,et al. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. , 2015, JAMA oncology.

[5] R. Langer,et al. Is Preoperative Chemotherapy Followed by Surgery the Appropriate Treatment for Signet Ring Cell Containing Adenocarcinomas of the Esophagogastric Junction and Stomach? , 2014, Annals of Surgical Oncology.